Kovacs Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2008
NCT00566007
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Kovacs Foundation, Palma de Mallorca, 07012, Spain

Active Ingredients

Drugs in Phase 2 Trials (2)

oxygen (1 trial)

ozone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intervertebral Disc Displacement (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2